Company Search:
Advanced Search
Sponsored Links
Therapix Biosciences Ltd Company Snapshot
Therapix Biosciences Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Therapix Biosciences Ltd with three other pharmaceutical manufacturers in Middle East: Can Fite Biopharma Ltd (2011 sales of 1.79 million Israel Shekels [US$491,196.30 ] ), Solegreen Ltd (3.57 million Israel Shekels [US$981,567.06 ] ), and Rosetta Genomics Ltd. (USA) (367,935.57 Israel Shekels [US$101,248.51 ] ).

Sales Analysis.
  Stock Performance Chart for Therapix Biosciences Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2017): .78
(Figures in Israel Shekels)
1 Week -3.3%   13 Weeks 1.6%  
4 Weeks 10.2%   52 Weeks -14.3%  
Therapix Biosciences Ltd Key Data:
  Ticker: THXBY Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2011 Sales 3,664,000
(Year Ending Jan 2012).
Employees: 10
  Currency: Israel Shekels Market Cap: 36,111,023
  Fiscal Yr Ends: December Shares Outstanding: 46,355,614
  Share Type: Closely Held Shares: 16,723,798
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.